MaxisIT Inc. is a United States-based startup dedicated to optimizing clinical trial outcomes with its purpose-fit and intelligent clinical data analytics platform. Founded in 2003, the company aims to improve clinical trial performance, mitigate risk, and optimize clinical outcomes. MaxisIT provides a centralized and reliable source of truth for diverse data types from various sources, offering life sciences companies real-time insight to shorten cycle time and increase return on investment. The company's solutions incorporate an end-to-end clinical data pipeline from intake to visualization, powered by AI/ML and metadata-centric approaches. With an impressive portfolio of over 3,000 clinical trials and an unparalleled 100% customer retention rate, MaxisIT's services are held in high regard for their quality and reliability. While specific details about the last investment and investors are not available, MaxisIT continues to drive innovation in the clinical data analytics space, positioning itself as a compelling prospect for potential investors.
There is no investment information
No recent news or press coverage available for MaxisIT Inc..